Kumiko Misu

Kumiko Misu

Auto-generated profile, based on publicly available information

Kumiko Misu

Center for Medical Genetics, Keio University School of Medicine, Tokyo, Japan

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2022 in Journal of Gynecologic Oncology
Verified
Journal Article
Open access
PDF file
TATomoko Akahane
Tomoko Akahane
KMKenta Masuda
Kenta Masuda
AHAkira Hirasawa
Akira Hirasawa
Yusuke KobayashiYusuke Kobayashi
Yusuke Kobayashi
AUArisa Ueki
Arisa Ueki
DADaisuke Aoki
Daisuke Aoki
Akahane T, et al. J Gynecol Oncol. 2022 Mar;33(4):e50. https://doi.org/10.3802/jgo.2022.33.e50

1 August 2020 in European Journal of Medical Genetics
Verified
Journal Article
Closed access
Yusuke KobayashiYusuke Kobayashi
Yusuke Kobayashi
TTTakashi Takeda
Takashi Takeda
HKHaruko Kunitomi
Haruko Kunitomi
AUArisa Ueki
Arisa Ueki
KMKumiko Misu
Kumiko Misu
DADaisuke Aoki
Daisuke Aoki


9 March 2026 in SSRN Electronic Journal
Verified
Preprint
Open access
DNDaisuke Nakato
Daisuke Nakato
RKRieko Komatsu
Rieko Komatsu
IOIkumi Ono
Ikumi Ono
KMKumiko Misu
Kumiko Misu
SNSatsuki Nakano
Satsuki Nakano
KKKenjiro Kosaki
Kenjiro Kosaki
Reflex sympathetic dystrophy (RSD), currently categorized within the spectrum of complex regional pain syndrome (CRPS), is typically considered an acquired disorder characterized by disproportionate pain, erythema, and autonomic changes. In contrast, inherited erythromelalgia is a genetic pain disorder most often caused by gain-of-function variants in SCN9A encoding the Nav1.7 sodium channel and usually presents with bilateral, symmetric distal limb pain and redness. Here, we describe a multigenerational family with a strictly hemisided, trauma-triggered neurovascular pain phenotype associated with a previously unreported heterozygous germline SCN9A variant (c.4784T>G, p.Leu1595Arg).Affected individuals experienced episodic attacks in which minor mechanical or physiological stimuli induced progressive unilateral erythema, warmth, and severe pain spreading from the site of injury and sharply demarcated at the midline, without contralateral involvement. Attacks lasted hours to nearly one day and tended to decrease with age. The variant was absent from population databases and co-segregated with the phenotype within the family, fulfilling ACMG/AMP criteria for likely pathogenicity.The consistent hemisided distribution cannot be explained by mosaicism and is instead compatible with activation of ipsilateral segmental nociceptive and neurovascular reflex circuits that function largely independently across the spinal midline. We propose that excessive positive feedback between C-fiber activation and axon reflex–mediated neurogenic inflammation underlies attack propagation and duration. This framework also suggests therapeutic benefit from agents that interrupt activity-dependent transmitter release, such as gabapentinoids.These findings expand the phenotypic spectrum of SCN9A-related pain disorders and provide a genetically anchored model for hemisided RSD/CRPS-like neurovascular pain.